Literature DB >> 21354263

Distinct regulation of B-type natriuretic peptide transcription by p38 MAPK isoforms.

Elina Koivisto1, Leena Kaikkonen, Heikki Tokola, Sampsa Pikkarainen, Jani Aro, Harri Pennanen, Teemu Karvonen, Jaana Rysä, Risto Kerkelä, Heikki Ruskoaho.   

Abstract

Persistent controversy underlies the functional roles of specific p38 MAPK isoforms in cardiac biology and regulation of hypertrophy-associated genes. Here we show that adenoviral gene transfer of p38β but not p38α increased B-type natriuretic peptide (BNP) mRNA levels in vitro as well as atrial natriuretic peptide mRNA levels both in vitro and in vivo. Overexpression of p38α, in turn, augmented the expression fibrosis-related genes connective tissue growth factor, basic fibroblast growth factor and matrix metalloproteinase-9 both in vitro and in vivo. p38β-induced BNP transcription was diminished by mutation of GATA-4 binding site, whereas overexpression of MKK6b, an upstream regulator of p38α and p38β, activated BNP transcription through both GATA-4 and AP-1. Overexpression of MKK3, upstream regulator of p38α, induced BNP transcription independently from AP-1 and GATA-4. These data provide new evidence for diversity in downstream targets and functional roles of p38 pathway kinases in regulation of hypertrophy-associated cardiac genes.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354263     DOI: 10.1016/j.mce.2011.02.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

1.  Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.

Authors:  Tsung-Jung Ho; Chi-Chang Huang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Eur J Appl Physiol       Date:  2011-12-09       Impact factor: 3.078

Review 2.  p38 MAP kinases in the heart.

Authors:  Tomohiro Yokota; Yibin Wang
Journal:  Gene       Date:  2015-09-20       Impact factor: 3.688

Review 3.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

Review 4.  Amyloidosis in Heart Failure.

Authors:  Sandra Ihne; Caroline Morbach; Laura Obici; Giovanni Palladini; Stefan Störk
Journal:  Curr Heart Fail Rep       Date:  2019-12

5.  The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.

Authors:  Annina Kelloniemi; Zoltan Szabo; Raisa Serpi; Juha Näpänkangas; Pauli Ohukainen; Olli Tenhunen; Leena Kaikkonen; Elina Koivisto; Zsolt Bagyura; Risto Kerkelä; Margret Leosdottir; Thomas Hedner; Olle Melander; Heikki Ruskoaho; Jaana Rysä
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Characterization of the regulatory mechanisms of activating transcription factor 3 by hypertrophic stimuli in rat cardiomyocytes.

Authors:  Elina Koivisto; Alicia Jurado Acosta; Anne-Mari Moilanen; Heikki Tokola; Jani Aro; Harri Pennanen; Hanna Säkkinen; Leena Kaikkonen; Heikki Ruskoaho; Jaana Rysä
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 7.  Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Authors:  G Merlini; I Lousada; Y Ando; A Dispenzieri; M A Gertz; M Grogan; M S Maurer; V Sanchorawala; A Wechalekar; G Palladini; R L Comenzo
Journal:  Leukemia       Date:  2016-07-15       Impact factor: 11.528

8.  WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function.

Authors:  Anne-Mari Moilanen; Jaana Rysä; Leena Kaikkonen; Teemu Karvonen; Erja Mustonen; Raisa Serpi; Zoltán Szabó; Olli Tenhunen; Zsolt Bagyura; Juha Näpänkangas; Pauli Ohukainen; Pasi Tavi; Risto Kerkelä; Margrét Leósdóttir; Björn Wahlstrand; Thomas Hedner; Olle Melander; Heikki Ruskoaho
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

Review 9.  p38 MAPK in cardioprotection - are we there yet?

Authors:  E D Martin; R Bassi; M S Marber
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 10.  Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events.

Authors:  Risto Kerkelä; Johanna Ulvila; Johanna Magga
Journal:  J Am Heart Assoc       Date:  2015-10-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.